SlideShare ist ein Scribd-Unternehmen logo
1 von 25
Downloaden Sie, um offline zu lesen
Golden Standard in
  Biobanking for Vitiligo
    and Rare Diseases	
  



             Igor	
  V.	
  Korobko,	
  
VR	
  Founda0on	
  Chief	
  Scien0fic	
  Director	
  	
  
What is a biobank for a specific disease?                                	
  
“... biobanks are defined as collections of samples
of human substances (e.g. cells, blood, tissue or
DNA) that are or can be associated with personal
data and information on their donors. Biobanks
have a twofold character, as collections of both
samples and data”.

European Medicines Agency. Draft concept paper on the development of a
guideline on biobanks issues relevant to pharmacogenetics	
  
Why there is a need for biobanks for rare
        and neglected diseases?                             	
  



•  Samples for lab research

•  Clinical data analysis “… to establish new patient stratification
   principles and for revealing unknown disease correlations”
 Jensen et al., Nature Review Genetics (2012) 13: 395-405

•  Irrelevant factors affecting the disease
Why there is a need for biobanks for rare
        and neglected diseases?      	
  
• Lengthy biosample collection

• Lack of standards in data and sample collection

• Networking problems
What biobank is needed for?              	
  
ü to fuel research with well-described biosample
  collection

ü to enable finding overseen correlations between
  clinical parameters

ü to identify factors (inducers, treatments) previously
  not linked to the disease

ü to efficiently enroll patients into clinical studies

                        and more ...
Good rare/neglected disease biobank
       ingredients: a recipe

ü  Standard protocol for data collection
ü  Standard protocol for biosample
    collection
ü  Networking
ü  Common database (make available for
    researchers, attach search engines and
    analytical tools)
ü  Ethical concerns
ü  Motivation for physicians
ü  Funding
Vitiligo Biobank:
implementation of the concept for a neglected disease            	
  




Vitiligo Biobank is an initiative launched, supported and operated
                     by the VR Foundation
Expecting impact of Vitiligo biobank on
          vitiligo management                         	
  
  •  Vitiligo is a complex multifactorial disease with diverse triggers
     and mechanisms of pathogenesis.

  •  Despite being one of the most common skin diseases, owing to
     its non-life threatening nature, vitiligo is truly neglected disease.

  •  Existing treatments have limited efficiency.



The need for research of vitiligo to understand mechanisms
of pathogenesis, to develop novel treatment modalities, to
offer personalized treatment options to patients.
Expecting impact of Vitiligo biobank on
          vitiligo management                   	
  
  Biobank would promote and speed up reaching these goals
                        through:
ü  expediting experimental (both lab & clinical) research

ü  revealing overseen correlations between clinical parameters

ü  repurposing existing treatments & identifying
    unconventional ways of disease management
Expecting impact of Vitiligo biobank on
         vitiligo management                   	
  

 ... But not only through enabling access to data and biosamples

Truly collaborative project between
researchers, clinicians and patients, in
pursuit for vitiligo therapy development
Vitiligo biobank: data collection     	
  
     Standard protocols for data collection
ü t akes into account all possibly informative
  parameters yet excluded those which are not
  important to save time at data collection

ü is compiled based on numerous physician's
  opinions and analytical analysis of revealed or
  possible correlation

ü is built based on tabulated data, an important issue
  for subsequent analysis
Vitiligo biobank today: data collection                    	
  
            Patient Biobank Record forms enveloping:
ü maximally tabulated data collection;
ü range of parameters carefully defined for all essential events to be
   recorded;
                        and designed for:
ü primary visits;
ü follow-up visits;
ü specific supplementary forms for transplantation procedures.

                    Guideline for data collection
ü to ensure quality and uniformity of the collected data, dataset
   labeling & ethical concern compliance.
Vitiligo biobank: sample collection             	
  
Standard protocols and guidelines for biosample
    collection depending on the sample type
               Types of collected samples
               Criteria for sample type selection:
 ü patient's compliance,
 ü usability in research for understanding of
    pathomechanism,
 ü usability as biosamples for routine clinical tests,
 ü suitability for ready-to-go sample collection,
 ü cost of collection,
 ü accessibility to proper storage conditions.
Vitiligo biobank today: sample collection                    	
  
               Serum                                  Blood
ü reading of versatile parameters    ü genetic research, present and
   (from cytokines/GF,                   future
   metabolites to microRNA)           ü no special intervention if
ü easy to admit for clinical use        collected along with serum
ü routine collection procedure
ü time-course/response analysis                    Hair bulbs
   opportunity
                                      ü limited genetic research
ü collected along with other blood
                                         capability
   tests thus having high patient
                                      ü no special requirements for
   tolerance
                                         collection and storage
 
     Vitiligo biobank: ethical concerns
Vitiligo bioblank implicates policy of strict
adherence to all applicable ethical concerns
              and requirements
Vitiligo biobank: networking         	
  
   Multiple sites for biosample and data collection
          enables robust growth of database


                 Implemented concept:

ü local storage of biosamples, centralized storage of
  data
ü biosamples are available for research on demand
ü availability is either physical or virtual
Vitiligo biobank: networking         	
  
         Benefits of the implemented concept:

ü no need for sample transportation so expenses are cut
ü no conflict with local legal issues
ü increase in biobank analytical power
ü broadening geography of vitiligo research
ü promoting local vitiligo research projects through the
  use of local biobank opportunities
Vitiligo biobank today: networking        	
  
Six locations worldwide operating now, several to
                   join shortly
Vitiligo biobank:
          data recording, storage and management	
  
Integrated solution for data recording, collection and
                        storage

ü data entry and analysis
ü datasets selection based on pre-set parameters
  (virtual patient enrollment)
ü biosample availability information
ü ensuring high compliance of the physician
Vitiligo biobank:
         data recording, storage and management	
  
                Database and more...

    Cloudy: a system providing capabilities for…

ü data storage in searchable and analyzable format
ü dynamic database field updates
ü entering and storage of non-tabulated data such as
   text and images
ü network access (with later local versions
   synchronized with database to be released)
... and more for physician & patient!
Biobank: attracting physicians	
  



                Cloudy system:

  merging data collection (research area) with
                capabilities for

easy and robust tracing of patient's disease
     conditions and treatment response
Biobank: attracting physicians	
  


                         Features:

ü Electronic medical record tuned up for vitiligo

ü Visit scheduling

ü One-click frequently used treatment protocol addition

ü Visualization of selected parameters in a time scale
Vitiligo biobank today: overview       	
  
Six locations worldwide operating now, several to
join shortly


More than 650 datasets were acquired since the
beginning of operation in July 2012


Cloudy smart interface and data collection electronic
system to be released soon
Welcome to join
     Vitiligo biobank :
in networking, research projects,
            funding	
  
Thank you for your
     attention !	
  


       www.vrfounda/on.org	
  
   Web:	
  vi/ligobiobank.org	
  
Email:	
  biobank@vrfounda/on.org	
  	
  	
  	
  

Weitere ähnliche Inhalte

Andere mochten auch

Carska, bernadicova puva specifics of vitiligo in childhood
Carska, bernadicova puva specifics of vitiligo in childhoodCarska, bernadicova puva specifics of vitiligo in childhood
Carska, bernadicova puva specifics of vitiligo in childhoodVR Foundation
 
Vitiligo comorbities by Prof. Michael Tharp
Vitiligo comorbities by Prof. Michael TharpVitiligo comorbities by Prof. Michael Tharp
Vitiligo comorbities by Prof. Michael TharpVR Foundation
 
Vitiligo - clinical classification by Dr. George Tiplica
Vitiligo - clinical classification by Dr. George TiplicaVitiligo - clinical classification by Dr. George Tiplica
Vitiligo - clinical classification by Dr. George TiplicaVR Foundation
 
Vitiligo : What's new in 2012 - Howard Fox Memorial Lecture, New York Academy...
Vitiligo : What's new in 2012 - Howard Fox Memorial Lecture, New York Academy...Vitiligo : What's new in 2012 - Howard Fox Memorial Lecture, New York Academy...
Vitiligo : What's new in 2012 - Howard Fox Memorial Lecture, New York Academy...VR Foundation
 
Kena leen cream and vitiligo
Kena leen cream and vitiligoKena leen cream and vitiligo
Kena leen cream and vitiligoDr. Hani Malkawi
 
Reuters: Pictures of the Year 2016 (Part 2)
Reuters: Pictures of the Year 2016 (Part 2)Reuters: Pictures of the Year 2016 (Part 2)
Reuters: Pictures of the Year 2016 (Part 2)maditabalnco
 

Andere mochten auch (8)

Carska, bernadicova puva specifics of vitiligo in childhood
Carska, bernadicova puva specifics of vitiligo in childhoodCarska, bernadicova puva specifics of vitiligo in childhood
Carska, bernadicova puva specifics of vitiligo in childhood
 
Antioxidants
Antioxidants  Antioxidants
Antioxidants
 
Vitiligo comorbities by Prof. Michael Tharp
Vitiligo comorbities by Prof. Michael TharpVitiligo comorbities by Prof. Michael Tharp
Vitiligo comorbities by Prof. Michael Tharp
 
Vitiligo - clinical classification by Dr. George Tiplica
Vitiligo - clinical classification by Dr. George TiplicaVitiligo - clinical classification by Dr. George Tiplica
Vitiligo - clinical classification by Dr. George Tiplica
 
Vitiligo : What's new in 2012 - Howard Fox Memorial Lecture, New York Academy...
Vitiligo : What's new in 2012 - Howard Fox Memorial Lecture, New York Academy...Vitiligo : What's new in 2012 - Howard Fox Memorial Lecture, New York Academy...
Vitiligo : What's new in 2012 - Howard Fox Memorial Lecture, New York Academy...
 
Vitiligo Q&A German
Vitiligo Q&A GermanVitiligo Q&A German
Vitiligo Q&A German
 
Kena leen cream and vitiligo
Kena leen cream and vitiligoKena leen cream and vitiligo
Kena leen cream and vitiligo
 
Reuters: Pictures of the Year 2016 (Part 2)
Reuters: Pictures of the Year 2016 (Part 2)Reuters: Pictures of the Year 2016 (Part 2)
Reuters: Pictures of the Year 2016 (Part 2)
 

Ähnlich wie Vitiligo biobank presentation dec 2012 yv ik

NordForsk Open Access Reykjavik 14-15/8-2014: Bbmri
NordForsk Open Access Reykjavik 14-15/8-2014: BbmriNordForsk Open Access Reykjavik 14-15/8-2014: Bbmri
NordForsk Open Access Reykjavik 14-15/8-2014: BbmriNordForsk
 
Derick Mitchell_Biobanking from the patient perspective.pdf
Derick Mitchell_Biobanking from the patient perspective.pdfDerick Mitchell_Biobanking from the patient perspective.pdf
Derick Mitchell_Biobanking from the patient perspective.pdfipposi
 
Informatics Principles of Modern Institutional Bio-banking: The Road Ahead
Informatics Principles of Modern Institutional Bio-banking: The Road AheadInformatics Principles of Modern Institutional Bio-banking: The Road Ahead
Informatics Principles of Modern Institutional Bio-banking: The Road AheadMike Hogarth, MD, FACMI, FACP
 
Biosample exchanges – the past, the current and the future – how do we make i...
Biosample exchanges – the past, the current and the future – how do we make i...Biosample exchanges – the past, the current and the future – how do we make i...
Biosample exchanges – the past, the current and the future – how do we make i...Pistoia Alliance
 
SMi Group's BioBanking 2018
SMi Group's BioBanking 2018SMi Group's BioBanking 2018
SMi Group's BioBanking 2018Dale Butler
 
EuroBioForum2014_speaker_bilbao
EuroBioForum2014_speaker_bilbaoEuroBioForum2014_speaker_bilbao
EuroBioForum2014_speaker_bilbaoEuroBioForum
 
Spanish national rare diseases-Dr. Manuel Posada
Spanish national rare diseases-Dr. Manuel PosadaSpanish national rare diseases-Dr. Manuel Posada
Spanish national rare diseases-Dr. Manuel PosadaData Science NIH
 
UC BRAID Biobanking
UC BRAID Biobanking UC BRAID Biobanking
UC BRAID Biobanking CTSI at UCSF
 
Biobanking market.pdf
Biobanking market.pdfBiobanking market.pdf
Biobanking market.pdfJohnson623453
 
Future Watch summary: Future growth opportunities in global biobanks market
Future Watch summary: Future growth opportunities in global biobanks marketFuture Watch summary: Future growth opportunities in global biobanks market
Future Watch summary: Future growth opportunities in global biobanks marketTeam Finland Future Watch
 
Bimcv labman eu-bi
Bimcv labman eu-biBimcv labman eu-bi
Bimcv labman eu-bimaigva
 
Country Status Reports on Agricultural Biotechnology - Bangladesh
Country Status Reports on Agricultural Biotechnology - BangladeshCountry Status Reports on Agricultural Biotechnology - Bangladesh
Country Status Reports on Agricultural Biotechnology - Bangladeshapaari
 
biobnk.pptx
biobnk.pptxbiobnk.pptx
biobnk.pptxALIY12
 
Development of platform techniques to produce cheap, eco-friendly and easy-to...
Development of platform techniques to produce cheap, eco-friendly and easy-to...Development of platform techniques to produce cheap, eco-friendly and easy-to...
Development of platform techniques to produce cheap, eco-friendly and easy-to...ILRI
 
SMi Groups' 4th annual BioBanking conference
SMi Groups' 4th annual BioBanking conferenceSMi Groups' 4th annual BioBanking conference
SMi Groups' 4th annual BioBanking conferenceDale Butler
 

Ähnlich wie Vitiligo biobank presentation dec 2012 yv ik (20)

NordForsk Open Access Reykjavik 14-15/8-2014: Bbmri
NordForsk Open Access Reykjavik 14-15/8-2014: BbmriNordForsk Open Access Reykjavik 14-15/8-2014: Bbmri
NordForsk Open Access Reykjavik 14-15/8-2014: Bbmri
 
Derick Mitchell_Biobanking from the patient perspective.pdf
Derick Mitchell_Biobanking from the patient perspective.pdfDerick Mitchell_Biobanking from the patient perspective.pdf
Derick Mitchell_Biobanking from the patient perspective.pdf
 
Informatics Principles of Modern Institutional Bio-banking: The Road Ahead
Informatics Principles of Modern Institutional Bio-banking: The Road AheadInformatics Principles of Modern Institutional Bio-banking: The Road Ahead
Informatics Principles of Modern Institutional Bio-banking: The Road Ahead
 
Biosample exchanges – the past, the current and the future – how do we make i...
Biosample exchanges – the past, the current and the future – how do we make i...Biosample exchanges – the past, the current and the future – how do we make i...
Biosample exchanges – the past, the current and the future – how do we make i...
 
SMi Group's BioBanking 2018
SMi Group's BioBanking 2018SMi Group's BioBanking 2018
SMi Group's BioBanking 2018
 
EuroBioForum2014_speaker_bilbao
EuroBioForum2014_speaker_bilbaoEuroBioForum2014_speaker_bilbao
EuroBioForum2014_speaker_bilbao
 
Spanish national rare diseases-Dr. Manuel Posada
Spanish national rare diseases-Dr. Manuel PosadaSpanish national rare diseases-Dr. Manuel Posada
Spanish national rare diseases-Dr. Manuel Posada
 
UC BRAID Biobanking
UC BRAID Biobanking UC BRAID Biobanking
UC BRAID Biobanking
 
Biobanking market.pdf
Biobanking market.pdfBiobanking market.pdf
Biobanking market.pdf
 
Biobanks: Patients’ Role and Expectations
Biobanks: Patients’ Role and ExpectationsBiobanks: Patients’ Role and Expectations
Biobanks: Patients’ Role and Expectations
 
Future Watch summary: Future growth opportunities in global biobanks market
Future Watch summary: Future growth opportunities in global biobanks marketFuture Watch summary: Future growth opportunities in global biobanks market
Future Watch summary: Future growth opportunities in global biobanks market
 
Bimcv labman eu-bi
Bimcv labman eu-biBimcv labman eu-bi
Bimcv labman eu-bi
 
Cloud MRM
Cloud MRM Cloud MRM
Cloud MRM
 
Julie Corfield
Julie CorfieldJulie Corfield
Julie Corfield
 
Country Status Reports on Agricultural Biotechnology - Bangladesh
Country Status Reports on Agricultural Biotechnology - BangladeshCountry Status Reports on Agricultural Biotechnology - Bangladesh
Country Status Reports on Agricultural Biotechnology - Bangladesh
 
0307 Mary Wang - Biobanks and registries
0307 Mary Wang - Biobanks and registries0307 Mary Wang - Biobanks and registries
0307 Mary Wang - Biobanks and registries
 
Bio Oxford
Bio OxfordBio Oxford
Bio Oxford
 
biobnk.pptx
biobnk.pptxbiobnk.pptx
biobnk.pptx
 
Development of platform techniques to produce cheap, eco-friendly and easy-to...
Development of platform techniques to produce cheap, eco-friendly and easy-to...Development of platform techniques to produce cheap, eco-friendly and easy-to...
Development of platform techniques to produce cheap, eco-friendly and easy-to...
 
SMi Groups' 4th annual BioBanking conference
SMi Groups' 4th annual BioBanking conferenceSMi Groups' 4th annual BioBanking conference
SMi Groups' 4th annual BioBanking conference
 

Kürzlich hochgeladen

Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...saminamagar
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 

Kürzlich hochgeladen (20)

Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 

Vitiligo biobank presentation dec 2012 yv ik

  • 1. Golden Standard in Biobanking for Vitiligo and Rare Diseases   Igor  V.  Korobko,   VR  Founda0on  Chief  Scien0fic  Director    
  • 2. What is a biobank for a specific disease?   “... biobanks are defined as collections of samples of human substances (e.g. cells, blood, tissue or DNA) that are or can be associated with personal data and information on their donors. Biobanks have a twofold character, as collections of both samples and data”. European Medicines Agency. Draft concept paper on the development of a guideline on biobanks issues relevant to pharmacogenetics  
  • 3. Why there is a need for biobanks for rare and neglected diseases?   •  Samples for lab research •  Clinical data analysis “… to establish new patient stratification principles and for revealing unknown disease correlations” Jensen et al., Nature Review Genetics (2012) 13: 395-405 •  Irrelevant factors affecting the disease
  • 4. Why there is a need for biobanks for rare and neglected diseases?   • Lengthy biosample collection • Lack of standards in data and sample collection • Networking problems
  • 5. What biobank is needed for?   ü to fuel research with well-described biosample collection ü to enable finding overseen correlations between clinical parameters ü to identify factors (inducers, treatments) previously not linked to the disease ü to efficiently enroll patients into clinical studies and more ...
  • 6. Good rare/neglected disease biobank ingredients: a recipe ü  Standard protocol for data collection ü  Standard protocol for biosample collection ü  Networking ü  Common database (make available for researchers, attach search engines and analytical tools) ü  Ethical concerns ü  Motivation for physicians ü  Funding
  • 7. Vitiligo Biobank: implementation of the concept for a neglected disease   Vitiligo Biobank is an initiative launched, supported and operated by the VR Foundation
  • 8. Expecting impact of Vitiligo biobank on vitiligo management   •  Vitiligo is a complex multifactorial disease with diverse triggers and mechanisms of pathogenesis. •  Despite being one of the most common skin diseases, owing to its non-life threatening nature, vitiligo is truly neglected disease. •  Existing treatments have limited efficiency. The need for research of vitiligo to understand mechanisms of pathogenesis, to develop novel treatment modalities, to offer personalized treatment options to patients.
  • 9. Expecting impact of Vitiligo biobank on vitiligo management   Biobank would promote and speed up reaching these goals through: ü  expediting experimental (both lab & clinical) research ü  revealing overseen correlations between clinical parameters ü  repurposing existing treatments & identifying unconventional ways of disease management
  • 10. Expecting impact of Vitiligo biobank on vitiligo management   ... But not only through enabling access to data and biosamples Truly collaborative project between researchers, clinicians and patients, in pursuit for vitiligo therapy development
  • 11. Vitiligo biobank: data collection   Standard protocols for data collection ü t akes into account all possibly informative parameters yet excluded those which are not important to save time at data collection ü is compiled based on numerous physician's opinions and analytical analysis of revealed or possible correlation ü is built based on tabulated data, an important issue for subsequent analysis
  • 12. Vitiligo biobank today: data collection   Patient Biobank Record forms enveloping: ü maximally tabulated data collection; ü range of parameters carefully defined for all essential events to be recorded; and designed for: ü primary visits; ü follow-up visits; ü specific supplementary forms for transplantation procedures. Guideline for data collection ü to ensure quality and uniformity of the collected data, dataset labeling & ethical concern compliance.
  • 13. Vitiligo biobank: sample collection   Standard protocols and guidelines for biosample collection depending on the sample type Types of collected samples Criteria for sample type selection: ü patient's compliance, ü usability in research for understanding of pathomechanism, ü usability as biosamples for routine clinical tests, ü suitability for ready-to-go sample collection, ü cost of collection, ü accessibility to proper storage conditions.
  • 14. Vitiligo biobank today: sample collection   Serum Blood ü reading of versatile parameters ü genetic research, present and (from cytokines/GF, future metabolites to microRNA) ü no special intervention if ü easy to admit for clinical use collected along with serum ü routine collection procedure ü time-course/response analysis Hair bulbs opportunity ü limited genetic research ü collected along with other blood capability tests thus having high patient ü no special requirements for tolerance collection and storage
  • 15.   Vitiligo biobank: ethical concerns Vitiligo bioblank implicates policy of strict adherence to all applicable ethical concerns and requirements
  • 16. Vitiligo biobank: networking   Multiple sites for biosample and data collection enables robust growth of database Implemented concept: ü local storage of biosamples, centralized storage of data ü biosamples are available for research on demand ü availability is either physical or virtual
  • 17. Vitiligo biobank: networking   Benefits of the implemented concept: ü no need for sample transportation so expenses are cut ü no conflict with local legal issues ü increase in biobank analytical power ü broadening geography of vitiligo research ü promoting local vitiligo research projects through the use of local biobank opportunities
  • 18. Vitiligo biobank today: networking   Six locations worldwide operating now, several to join shortly
  • 19. Vitiligo biobank: data recording, storage and management   Integrated solution for data recording, collection and storage ü data entry and analysis ü datasets selection based on pre-set parameters (virtual patient enrollment) ü biosample availability information ü ensuring high compliance of the physician
  • 20. Vitiligo biobank: data recording, storage and management   Database and more... Cloudy: a system providing capabilities for… ü data storage in searchable and analyzable format ü dynamic database field updates ü entering and storage of non-tabulated data such as text and images ü network access (with later local versions synchronized with database to be released) ... and more for physician & patient!
  • 21. Biobank: attracting physicians   Cloudy system: merging data collection (research area) with capabilities for easy and robust tracing of patient's disease conditions and treatment response
  • 22. Biobank: attracting physicians   Features: ü Electronic medical record tuned up for vitiligo ü Visit scheduling ü One-click frequently used treatment protocol addition ü Visualization of selected parameters in a time scale
  • 23. Vitiligo biobank today: overview   Six locations worldwide operating now, several to join shortly More than 650 datasets were acquired since the beginning of operation in July 2012 Cloudy smart interface and data collection electronic system to be released soon
  • 24. Welcome to join Vitiligo biobank : in networking, research projects, funding  
  • 25. Thank you for your attention !   www.vrfounda/on.org   Web:  vi/ligobiobank.org   Email:  biobank@vrfounda/on.org